Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

[Interstitial collagenase, gelatinases A and B and their endogenous inhibitors in squamous cell cervical carcinomas].

Ryzhakova OS, Zavalishina LÉ, Andreeva IuIu, Solov'eva NI.

Biomed Khim. 2013 Jan-Feb;59(1):55-64. Russian.

PMID:
23650722
3.

[Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].

Solov'eva NI, Timoshenko OS, Kugaevskaia EV, Andreeva IuIu, Zavalishina LE.

Bioorg Khim. 2014 Nov-Dec;40(6):743-51. Russian.

PMID:
25895371
4.
5.

[Membrane type 1 matrix metalloproteinase (MT1-MMP) and the regulators of its activity as invasive factors in squamous cell cervical carcinomas].

Timoshenko OS, Gureeva TA, Kugaevskaia EV, Solov'eva NI.

Biomed Khim. 2014 Nov-Dec;60(6):683-8. Russian.

PMID:
25552509
6.

Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.

Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T.

Br J Cancer. 1998 Jun;77(12):2239-45.

7.

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.

Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, Suzuki H.

Invasion Metastasis. 1998-1999;18(3):134-41.

PMID:
10474026
9.

[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis].

Kondakova IV, Klisho EV, savenkova OV, Kakurina GV, Choĭnzonov EL, Shishkin DA, Mukhamedov MP.

Biomed Khim. 2008 Sep-Oct;54(5):555-60. Russian.

PMID:
19105397
10.

Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.

Iwasaki M, Nishikawa A, Fujimoto T, Akutagawa N, Manase K, Endo T, Yoshida K, Maekawa R, Yoshioka T, Kudo R.

Gynecol Oncol. 2002 Apr;85(1):103-7.

PMID:
11925127
11.

[Expression of gelatinases A and B and their endogenous regulators in immortal and transformed fibroblasts].

Solov'eva NI, Vinokurova SV, Ryzhakova OS, Gureeva TA, Tsvetkova IV.

Biomed Khim. 2009 Jul-Aug;55(4):441-50. Russian.

PMID:
20000122
12.

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.

Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA.

Cancer. 2002 Mar 1;94(5):1466-75.

13.

Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Anticancer Res. 2006 Mar-Apr;26(2B):1543-56.

14.
15.
16.

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R.

Gynecol Oncol. 1999 Jun;73(3):372-82.

PMID:
10366463
17.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

18.

[Matrix metalloproteinases 2 and 9, their endogenous regulators, and angiotensin-converting enzyme in cervical squamous cell carcinoma].

Timoshenko OS, Kugaevskaya EV, Gureeva TA, Zavalishina LE, Andreeva YY, Solovуeva NI.

Arkh Patol. 2015 Sep-Oct;77(5):31-35. doi: 10.17116/patol201577531-35. Russian.

PMID:
26978018
19.

Stromal cells play a role in cervical cancer progression mediated by MMP-2 protein.

Fernandes T, de Angelo-Andrade LA, Morais SS, Pinto GA, Chagas CA, Maria-Engler SS, Zeferino LC.

Eur J Gynaecol Oncol. 2008;29(4):341-4.

PMID:
18714566
20.

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.

Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.

Int J Mol Med. 2005 Oct;16(4):541-6.

PMID:
16142384

Supplemental Content

Support Center